Patent · US Active

Methods useful in the treatment of bone resorption diseases

US7507715B2 · kind B2 · utility

3Cited by

40References

1Claims

0Family size

Assignee

NPS Allelix Corp. · CA

Inventors

John Dietrich · Mississauga, CA
Sverker Ljunghall · Mölndal, SE
Sven Sjogren · Mölndal, SE

Key dates

Filing date	Dec 19, 2005
Grant date	Mar 24, 2009
Priority date	—
Expiry date	Aug 5, 2026

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P19/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The invention relates to a combined pharmaceutical preparation comprising parathyroid hormone and a bone resorption inhibitor, said preparation being adapted for (a) the administration of parathyroid hormone during a period of approximately 6 to 24 months; (b) after the administration of parathyroid hormone has been terminated, the administration of a bone resorption inhibitor during a period of approximately 12 to 36 months.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.